REGEMAT 3D is Developing Bioprinting Technologies

Published by , January 12, 2018 12:51 pm

(3DPrint.com) REGEMAT 3D is pioneering the development of bioprinting technologies. The Spanish startup’ founder and CEO José Manuel Baena isn’t new to 3D printing; he also founded BRECA Health Care in 2011, which was responsible for one of the first 3D printed implants. Baena thinks that the combination of synthetic 3D printed implants and bioprinted materials has a lot of potential for injury regeneration. Baena said, “Now with 3D printing you can offer a customized solution combining a synthetic medical device with a biodegradable bioprinted one and even autologous cells of the patient to enhance the regeneration. . A custom made synthetic medical device will help to hold the structure and promote the integration of the bioprinted living tissue.”
The original version of the platform was designed to treat cartilage degeneration and degenerative joint diseases, due to the frequency of these types of ailments. In the last three years the company has expanded the use of the system to other tissue applications. Drug development is another area of interest. If a user needs a bioprinter for another application, however, they only need to specify what and REGEMAT 3D will develop a system to meet their needs.